Literature DB >> 9403953

Methods of correcting for multiple testing: operating characteristics.

B W Brown1, K Russell.   

Abstract

We examine the operating characteristics of 17 methods for correcting p-values for multiple testing on synthetic data with known statistical properties. These methods are derived p-values only and not the raw data. With the test cases, we systematically varied the number of p-values, the proportion of false null hypotheses, the probability that a false null hypothesis would result in a p-value less than 5 per cent and the degree of correlation between p-values. We examined the effect of each of these factors on family-wise and false negative error rates and compared the false negative error rates of methods with an acceptable family-wise error. Only four methods were not bettered in this comparison. Unfortunately, however, a uniformly best method of those examined does not exist. A suggested strategy for examining corrections uses a succession of methods that are increasingly lax in family-wise error. A computer program for these corrections is available.

Entities:  

Mesh:

Year:  1997        PMID: 9403953     DOI: 10.1002/(sici)1097-0258(19971130)16:22<2511::aid-sim693>3.0.co;2-4

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  35 in total

1.  Efficient computation of significance levels for multiple associations in large studies of correlated data, including genomewide association studies.

Authors:  Frank Dudbridge; Bobby P C Koeleman
Journal:  Am J Hum Genet       Date:  2004-07-19       Impact factor: 11.025

2.  Quantitative temporal lobe differences: autism distinguished from controls using classification and regression tree analysis.

Authors:  E Shannon Neeley; Erin D Bigler; Lori Krasny; Sally Ozonoff; William McMahon; Janet E Lainhart
Journal:  Brain Dev       Date:  2007-01-03       Impact factor: 1.961

3.  A methylome-wide study of aging using massively parallel sequencing of the methyl-CpG-enriched genomic fraction from blood in over 700 subjects.

Authors:  Joseph L McClay; Karolina A Aberg; Shaunna L Clark; Srilaxmi Nerella; Gaurav Kumar; Lin Y Xie; Alexandra D Hudson; Aki Harada; Christina M Hultman; Patrik K E Magnusson; Patrick F Sullivan; Edwin J C G Van Den Oord
Journal:  Hum Mol Genet       Date:  2013-10-16       Impact factor: 6.150

4.  Acupuncture for 'frequent attenders' with medically unexplained symptoms: a randomised controlled trial (CACTUS study).

Authors:  Charlotte Paterson; Rod S Taylor; Peter Griffiths; Nicky Britten; Sue Rugg; Jackie Bridges; Bruce McCallum; Gerad Kite
Journal:  Br J Gen Pract       Date:  2011-06       Impact factor: 5.386

5.  Genome-wide association study of patient-rated and clinician-rated global impression of severity during antipsychotic treatment.

Authors:  Shaunna L Clark; Renan P Souza; Daniel E Adkins; Karolina Aberg; József Bukszár; Joseph L McClay; Patrick F Sullivan; Edwin J C G van den Oord
Journal:  Pharmacogenet Genomics       Date:  2013-02       Impact factor: 2.089

6.  Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis.

Authors:  Joyce B J van Meurs; Thomas A Trikalinos; Stuart H Ralston; Susana Balcells; Maria Luisa Brandi; Kim Brixen; Douglas P Kiel; Bente L Langdahl; Paul Lips; Osten Ljunggren; Roman Lorenc; Barbara Obermayer-Pietsch; Claes Ohlsson; Ulrika Pettersson; David M Reid; Francois Rousseau; Serena Scollen; Wim Van Hul; Lidia Agueda; Kristina Akesson; Lidia I Benevolenskaya; Serge L Ferrari; Göran Hallmans; Albert Hofman; Lise Bjerre Husted; Marcin Kruk; Stephen Kaptoge; David Karasik; Magnus K Karlsson; Mattias Lorentzon; Laura Masi; Fiona E A McGuigan; Dan Mellström; Leif Mosekilde; Xavier Nogues; Huibert A P Pols; Jonathan Reeve; Wilfried Renner; Fernando Rivadeneira; Natasja M van Schoor; Kurt Weber; John P A Ioannidis; André G Uitterlinden
Journal:  JAMA       Date:  2008-03-19       Impact factor: 56.272

7.  Genomewide association for schizophrenia in the CATIE study: results of stage 1.

Authors:  P F Sullivan; D Lin; J-Y Tzeng; E van den Oord; D Perkins; T S Stroup; M Wagner; S Lee; F A Wright; F Zou; W Liu; A M Downing; J Lieberman; S L Close
Journal:  Mol Psychiatry       Date:  2008-03-18       Impact factor: 15.992

8.  Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs.

Authors:  D E Adkins; K Aberg; J L McClay; J Bukszár; Z Zhao; P Jia; T S Stroup; D Perkins; J P McEvoy; J A Lieberman; P F Sullivan; E J C G van den Oord
Journal:  Mol Psychiatry       Date:  2010-03-02       Impact factor: 15.992

9.  A new multitest correction (SGoF) that increases its statistical power when increasing the number of tests.

Authors:  Antonio Carvajal-Rodríguez; Jacobo de Uña-Alvarez; Emilio Rolán-Alvarez
Journal:  BMC Bioinformatics       Date:  2009-07-08       Impact factor: 3.169

10.  Analysis of group randomized trials with multiple binary endpoints and small number of groups.

Authors:  Ji-Hyun Lee; Michael J Schell; Richard Roetzheim
Journal:  PLoS One       Date:  2009-10-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.